In this Dose of Health episode, Abhishek sits down with pharmacist and NHS project manager Deen Somally to unpack AI in healthcare—from real-world triage (a Lyme disease scare) to headline breakthroughs in cancer detection. We break down how AI blood tests for ovarian cancer and Clarity’s FDA-authorized AI for predicting breast cancer risk could shift outcomes through earlier screening, lower costs, and smarter pathways in the NHS. We also dig into the ANI vs AGI vs ASI ladder in plain English, ask whether patients should trust AI vs doctor first, and debate the hard questions: accuracy, governance, MHRA/NICE/FDA timelines, and the economics of rolling out preventive screening at scale.If you’re a clinician, policymaker, or patient curious about early cancer detection, AI diagnostics, and health data privacy (GDPR), this conversation is for you. Learn how AI agents might run future clinics, why 2029 keeps popping up in AGI predictions, and what decentralised health records could mean for ownership of your data. Watch now to hear pragmatic takes from the frontline of pharmacy and NHS transformation—and drop your questions for next week’s Q&A on AI in medicine.